ZBI Equities’s PHARMACYCLICS INC PCYC Stock Holding History

ZBI Equities’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-385,814	Closed	-$40.8M	–	23
2013 Q4	$40.8M	Buy	+385,814	New	+$46.8M	2.21%	18

Other funds holding PCYC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ZBI Equities's PCYC Position: Q1 2014 in Review

ZBI Equities sold out of PHARMACYCLICS INC (PCYC) in Q1 2014, closing a stake of 385,814 shares — an estimated $40.8M sold.

ZBI Equities first reported a position in PCYC in Q4 2013 and held it in 1 quarter. The position peaked at $40.8M in Q4 2013. 280 funds tracked by Wall St. Rank hold PCYC as of Q1 2014.

ZBI Equities reported no remaining PHARMACYCLICS INC position as of Q1 2014 after selling out during the quarter.
ZBI Equities sold 385,814 PHARMACYCLICS INC shares in Q1 2014, an estimated $40.8M.
ZBI Equities first reported a position in PHARMACYCLICS INC in Q4 2013 and held it in 1 quarter.
ZBI Equities's PHARMACYCLICS INC position peaked at $40.8M in Q4 2013.
280 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q1 2014.

Based on ZBI Equities's 13F filing for Q1 2014.